A Phase 1, Placebo-Controlled, Crossover, Subject- And Investigator-Blind, Sponsor-Open Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of A Modified-Release Formulation Of PF-05180999 In Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2014
At a glance
- Drugs PF-5180999 (Primary) ; Cetirizine
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors Pfizer
- 07 May 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 21 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Feb 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.